Skip to main content
. 2010 Sep 8;2010(9):CD008418. doi: 10.1002/14651858.CD008418.pub2

2.1. Analysis.

2.1

Comparison 2 Formoterol versus short‐acting beta2‐agonist (background ICS use), Outcome 1 Patients with an exacerbation requiring a course of oral corticosteroids.